Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 26, 2023

SELL
$12.42 - $15.62 $14,220 - $17,884
-1,145 Reduced 1.81%
62,103 $0
Q3 2022

Oct 28, 2022

BUY
$12.8 - $28.65 $50,995 - $114,141
3,984 Added 6.72%
63,248 $796,000
Q2 2022

Aug 02, 2022

SELL
$13.12 - $15.03 $13,093 - $14,999
-998 Reduced 1.66%
59,264 $868,000
Q1 2022

Apr 27, 2022

SELL
$13.54 - $15.35 $21,487 - $24,360
-1,587 Reduced 2.57%
60,262 $862,000
Q4 2021

Feb 18, 2022

SELL
$13.17 - $16.4 $69,814 - $86,936
-5,301 Reduced 7.89%
61,849 $843,000
Q3 2021

Nov 22, 2021

SELL
$16.3 - $17.26 $2.04 Million - $2.16 Million
-125,189 Reduced 65.09%
67,150 $1.1 Million
Q2 2021

Aug 26, 2021

BUY
$16.55 - $18.64 $3,972 - $4,473
240 Added 0.12%
192,339 $3.24 Million
Q1 2021

Apr 28, 2021

BUY
$16.71 - $19.9 $106,476 - $126,802
6,372 Added 3.43%
192,099 $3.51 Million
Q4 2020

Jan 28, 2021

BUY
$15.39 - $18.97 $104,021 - $128,218
6,759 Added 3.78%
185,727 $3.38 Million
Q3 2020

Oct 30, 2020

SELL
$17.1 - $19.19 $23,153 - $25,983
-1,354 Reduced 0.75%
178,968 $3.19 Million
Q2 2020

Jul 31, 2020

BUY
$14.59 - $19.5 $137,102 - $183,241
9,397 Added 5.5%
180,322 $3.23 Million
Q1 2020

May 01, 2020

SELL
$13.02 - $20.31 $77,469 - $120,844
-5,950 Reduced 3.36%
170,925 $2.59 Million
Q4 2019

Feb 07, 2020

SELL
$16.88 - $20.83 $7,207 - $8,894
-427 Reduced 0.24%
176,875 $3.49 Million
Q3 2019

Oct 31, 2019

SELL
$16.15 - $17.99 $91,651 - $102,093
-5,675 Reduced 3.1%
177,302 $3.05 Million
Q2 2019

Aug 02, 2019

SELL
$16.58 - $20.49 $46,805 - $57,843
-2,823 Reduced 1.52%
182,977 $0
Q1 2019

May 02, 2019

BUY
$16.7 - $21.52 $1.46 Million - $1.88 Million
87,427 Added 88.87%
185,800 $0
Q4 2018

Feb 06, 2019

BUY
$15.64 - $21.1 $1.54 Million - $2.08 Million
98,373 New
98,373 $1.99 Million

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $43.1B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.